paclitaxel and Ewing Sarcoma
paclitaxel has been researched along with Ewing Sarcoma in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 3 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Aschero, R; Balaguer-Lluna, L; Baulenas-Farres, M; Burgueño, V; Carcaboso, AM; Castillo-Ecija, H; Cuadrado-Vilanova, M; de Alava, E; Lavarino, C; Martinez-Velasco, N; Mora, J; Olaciregui, NG; Pascual-Pasto, G; Perez-Jaume, S; Resa-Pares, C; Tirado, OM; Vila-Ubach, M | 1 |
Amoroso, L; Bisogno, G; Casanova, M; Castel, V; Chen, N; Chisholm, JC; Doz, F; Fagioli, F; Gerber, NU; Hingorani, P; le Bruchec, Y; Marquez-Vega, C; Melcón, SG; Moreno, L; Ruggiero, A; Simcock, M; Slepetis, R; Vassal, G | 1 |
Bas, O; Ceylan, F; Dizdar, O; Guven, DC; Kilickap, S; Yildirim, HC | 1 |
Cripe, TP; Currier, M; Eaves, D; Wagner, LM; Yin, H | 1 |
Guan, H; Jia, SF; Kleinerman, ES; Stewart, J; Zhou, Z | 1 |
Duan, X; Guan, H; Kleinerman, ES; Zhou, Z | 1 |
Arano Bermejo, JI; Cabañas Navarro, L; Capote Armas, LF; González-Palacios Martínez, F; Reguero Callejas, ME; Ruiz Tovar, J | 1 |
Guo, W; Tang, S; Tang, XD; Yang, Y | 1 |
Asrari, F; Attawia, MA; Borden, MD; Herbert, KM; Katti, DS; Laurencin, CT; Uhrich, KE | 1 |
Trials
1 trial(s) available for paclitaxel and Ewing Sarcoma
Article | Year |
---|---|
Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network.
Topics: Adolescent; Age Factors; Albumins; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Europe; Female; Humans; Infant; Male; Neuroblastoma; Paclitaxel; Progression-Free Survival; Rhabdomyosarcoma; Sarcoma, Ewing; Time Factors; Tissue Distribution; Young Adult | 2020 |
Other Studies
8 other study(ies) available for paclitaxel and Ewing Sarcoma
Article | Year |
---|---|
Low Bcl-2 is a robust biomarker of sensitivity to nab-paclitaxel in Ewing sarcoma.
Topics: Antineoplastic Agents; Biomarkers; Bone Neoplasms; Child; Humans; Osteonectin; Paclitaxel; Rhabdomyosarcoma; Sarcoma, Ewing | 2023 |
Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Humans; Immunotherapy; Male; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Sarcoma, Ewing | 2021 |
Preclinical evaluation of nanoparticle albumin-bound paclitaxel for treatment of pediatric bone sarcoma.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Bone Neoplasms; Cell Line, Tumor; Child; Drug Evaluation, Preclinical; Female; Humans; Mice; Nanoparticles; Osteonectin; Osteosarcoma; Paclitaxel; Sarcoma, Ewing | 2014 |
Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Down-Regulation; Drug Interactions; Female; Humans; Paclitaxel; Receptor, ErbB-2; Sarcoma, Ewing; Trastuzumab; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2005 |
Zoledronic acid inhibits primary bone tumor growth in Ewing sarcoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Density Conservation Agents; Bone Neoplasms; Cell Proliferation; Diphosphonates; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Glycoproteins; Humans; Imidazoles; Immunoenzyme Techniques; Mice; Mice, Nude; Osteoclasts; Osteoprotegerin; Paclitaxel; Radiography; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma, Ewing; Zoledronic Acid | 2005 |
Malignant mixed Mullerian tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Fatal Outcome; Female; Femoral Neoplasms; Humans; Hysterectomy; Ifosfamide; Ilium; Middle Aged; Mixed Tumor, Mullerian; Neoplasms, Second Primary; Ovariectomy; Paclitaxel; Palliative Care; Pelvic Neoplasms; Prognosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Spinal Neoplasms; Uterine Neoplasms | 2006 |
[Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Child; Etoposide; Female; Follow-Up Studies; Humans; Male; Osteosarcoma; Oxides; Paclitaxel; Sarcoma, Ewing; Treatment Outcome | 2006 |
Regional drug delivery with radiation for the treatment of Ewing's sarcoma. In vitro development of a taxol release system.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Bone Neoplasms; Cell Cycle; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Delivery Systems; Flow Cytometry; Hexanes; Humans; Microscopy, Electron, Scanning; Microspheres; Paclitaxel; Particle Size; Polymers; Radiation-Sensitizing Agents; Sarcoma, Ewing; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2001 |